Publikationen in Zusammenarbeit mit Forschern von University of Bologna (49)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

    The Journal of experimental medicine, Vol. 221, Núm. 2

2023

  1. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  2. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  3. Position statement: Recommendations on the diagnosis and treatment of Malassezia folliculitis

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 7, pp. 1268-1275

  4. The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580

2022

  1. It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey

    World Journal of Emergency Surgery, Vol. 17, Núm. 1

  2. Occurrence, associated factors and soft tissue reconstructive therapy for buccal soft tissue dehiscence at dental implants: Consensus report of group 3 of the DGI/SEPA/Osteology Workshop

    Clinical Oral Implants Research, Vol. 33, Núm. S23, pp. 137-144

2021

  1. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4529-4543

  2. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study

    Translational Psychiatry, Vol. 11, Núm. 1

2020

  1. European lipodystrophy registry: Background and structure

    Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1

  2. Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study

    The Lancet Neurology, Vol. 19, Núm. 10, pp. 840-848

  3. Premorbid Adjustment and IQ in Patients with First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship with Cannabis Use

    Schizophrenia Bulletin, Vol. 46, Núm. 3, pp. 517-529

  4. Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis

    European journal of endocrinology, Vol. 182, Núm. 1, pp. 11-21

  5. The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme

    Social Psychiatry and Psychiatric Epidemiology, Vol. 55, Núm. 5, pp. 645-657

2019

  1. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients

    World Journal of Emergency Surgery, Vol. 14, Núm. 1

  2. A survey among dermatologists: diagnostics of superficial fungal infections – what is used and what is needed to initiate therapy and assess efficacy?

    Journal of the European Academy of Dermatology and Venereology, Vol. 33, Núm. 2, pp. 421-427

  3. Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning

    Experimental and Molecular Medicine, Vol. 51, Núm. 8

  4. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature

  5. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

    The Lancet Psychiatry, Vol. 6, Núm. 5, pp. 427-436